Merrimack Pharmaceuticals
MACK
$14.98
Share price
1.63%
Change (1 day)
18.98%
Change (1 year)
Categories
Number of shares outstanding for Merrimack Pharmaceuticals (MACK)
Number of shares outstanding as of May 2024 : 14,321,000
According to Merrimack Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 14,321,000. At the end of 2023 the company had 14,321,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Merrimack Pharmaceuticals from 2019 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 14.32 M | 6.79% |
| 2022 | 13.41 M | 0% |
| 2021 | 13.41 M | 0.22% |
| 2020 | 13.38 M | 0.16% |
| 2019 | 13.35 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 2,507,200,000 | 17,407.16% | 🇫🇷 France |
 Geron GERN | 594,977,503 | 4,054.58% | 🇺🇸 USA |
 Clovis Oncology CLVS | 144,625,000 | 909.88% | 🇺🇸 USA |
 AVEO Oncology
AVEO | 34,618,000 | 141.73% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 5,410,000 | -62.22% | 🇺🇸 USA |